RNA NanoBiotics
Developer of RNA-based nanoparticle delivery systems for targeted delivery of therapeutic payloads to cancer cells. Focuses on incorporating nucleic acid therapeutics (RNAi, miRNA), nucleosides, radioisotopes and chemotherapeutics into RNA-based nanoparticles and using aptamer-mediated targeting to improve delivery, solubility of hydrophobic drugs, and enable combination therapy approaches with a view toward clinical translation.
Industries
N/A
Nr. of Employees
small (1-50)
RNA NanoBiotics
Products
RNA nanoparticle delivery platform
A platform for engineering RNA-based nanoparticles that carry and deliver combinations of RNA therapeutics, nucleosides, radioisotopes and chemotherapeutic agents with aptamer-mediated targeting.
RNA nanoparticle delivery platform
A platform for engineering RNA-based nanoparticles that carry and deliver combinations of RNA therapeutics, nucleosides, radioisotopes and chemotherapeutic agents with aptamer-mediated targeting.
Services
Engagements for investment, licensing or partnership to advance RNA nanoparticle-based delivery technologies toward clinical development.
Engagements for investment, licensing or partnership to advance RNA nanoparticle-based delivery technologies toward clinical development.
Expertise Areas
- Targeted drug delivery
- RNA therapeutics (RNAi and microRNA)
- Nanobiotechnology
- Aptamer-based targeting
Key Technologies
- RNA nanotechnology
- RNA nanoparticles
- Aptamer-mediated targeting
- RNA interference (RNAi)
News & Updates
Publication listed on the site related to core technologies.
Publication listed on the site related to core technologies.
Publication listed on the site related to core technologies.
Publication describing use of RNA nanotechnology to improve solubility and targeted delivery of hydrophobic antitumor drugs.
Publication listed on the site related to nanobiotechnology tools.
Publication PDF listed on the site.
Publication listed on the site related to core technologies.
Publication listed on the site related to core technologies.
Publication listed on the site related to core technologies.
Publication describing use of RNA nanotechnology to improve solubility and targeted delivery of hydrophobic antitumor drugs.
Publication listed on the site related to nanobiotechnology tools.
Publication PDF listed on the site.